roi-pr-343-193.png
BTCS Retires Convertible Note Early, Eliminates Potential Equity Dilution
September 27, 2021 09:21 ET | BTCS Inc.
Silver Spring, MD, Sept. 27, 2021 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology focused company, is pleased to announce that the Company has paid...
2020 Half-year results: Stronger financial position and research programs moving forward despite the international context
October 01, 2020 12:30 ET | Deinove
2020 Half-year results: Stronger financial position and research programs moving forward despite the international context Clinical program for the antibiotic candidate DNV3837 continues, with the...
logo.png
Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates
November 07, 2019 07:05 ET | Corbus Pharmaceuticals Holdings, Inc.
Phase 3 “RESOLVE-1” study of lenabasum for treatment of systemic sclerosis on track for topline results in summer of 2020Systemic sclerosis is a rare autoimmune disease affecting ~200,000 people in...
Logo.png
Update Announcement regarding fundraising and financial position
February 18, 2019 12:00 ET | Gate Ventures Plc
Gate Ventures PLCUpdate Announcement regarding fundraising and financial positionISIN Number: GB00BYX2WP92TICKER: GATEGate Ventures PLCPress ReleaseFebruary 18, 2019 Gate Ventures PLC ("Gate...